MLchartDataset catalogue

Trisenox

Term · Oncology and biomedicine · MLC-T-ONC-008916

A drug used to treat acute promyelocytic leukemia that has a certain chromosome abnormality or a fusion gene called PML::RARA. It is used with tretinoin in some newly diagnosed adults. It is also used alone in patients whose cancer has not gotten better or has come back after treatment with other anticancer drugs. Trisenox is also being studied in the treatment of other types of cancer. Trisenox damages a fusion protein made by the PML::RARA fusion gene. This may help keep cancer cells from growing and may kill them. Also called arsenic trioxide.

Table 1. Record
IdentifierMLC-T-ONC-008916
FieldOncology and biomedicine
Synonymsarsenic trioxide
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008916",
  "term": "Trisenox",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat acute promyelocytic leukemia that has a certain chromosome abnormality or a fusion gene called PML::RARA. It is used with tretinoin in some newly diagnosed adults. It is also used alone in patients whose cancer has not gotten better or has come back after treatment with other anticancer drugs. Trisenox is also being studied in the treatment of other types of cancer. Trisenox damages a fusion protein made by the PML::RARA fusion gene. This may help keep cancer cells from growing and may kill them. Also called arsenic trioxide.",
  "synonyms": [
    "arsenic trioxide"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/trisenox/"
}

Record 16,735 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.